In acute myocardial infarction patients, does adding a traditional Chinese medicine compound to standard treatments improve outcomes?

Researchers investigated whether Tongxinluo, a Chinese medicinal compound, could improve clinical outcomes among ST-segment elevation myocardial infarction patients.

Related Keywords

China ,Chinese , ,Traditional Chinese Medicine Compound ,Clinical Outcomes ,Patients With Acute Myocardial Infarction The ,Image Credit ,Image Point ,Compound ,Medicine ,Myocardial Infarction ,Ngiotensin ,Cardiovascular Disease ,Clinical Trial ,Hospital ,N Vitro ,Ortality ,Placebo ,Eceptor ,Stroke ,Translation ,